S. Neslihan Alpay

669 total citations
7 papers, 438 citations indexed

About

S. Neslihan Alpay is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, S. Neslihan Alpay has authored 7 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Cell Biology and 2 papers in Oncology. Recurrent topics in S. Neslihan Alpay's work include Autophagy in Disease and Therapy (2 papers), Retinoids in leukemia and cellular processes (2 papers) and Glycosylation and Glycoproteins Research (1 paper). S. Neslihan Alpay is often cited by papers focused on Autophagy in Disease and Therapy (2 papers), Retinoids in leukemia and cellular processes (2 papers) and Glycosylation and Glycoproteins Research (1 paper). S. Neslihan Alpay collaborates with scholars based in United States and Egypt. S. Neslihan Alpay's co-authors include Bülent Özpolat, Sukhen C. Ghosh, Jim Klostergaard, Abdel‐Aziz H. Abdel‐Aziz, Ahmed A. Ashour, Longfei Huo, İbrahim Tekedereli, Gabriel Lopez‐Berestein, Anil K. Sood and Ahmed M. Mansour and has published in prestigious journals such as PLoS ONE, Journal of Cellular and Molecular Medicine and APOPTOSIS.

In The Last Decade

S. Neslihan Alpay

7 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Neslihan Alpay United States	6	308	84	71	70	49	7	438
Bentham Science Publisher SiddikUzzaman India	11	281 0.9×	65 0.8×	43 0.6×	83 1.2×	47 1.0×	18	467
Qie Guo China	13	209 0.7×	77 0.9×	89 1.3×	100 1.4×	60 1.2×	41	497
Arul Goel United States	7	237 0.8×	88 1.0×	56 0.8×	87 1.2×	72 1.5×	13	438
Dapeng Wei China	12	301 1.0×	152 1.8×	121 1.7×	87 1.2×	67 1.4×	51	556
Afshin Nikkhoo Iran	9	230 0.7×	83 1.0×	68 1.0×	98 1.4×	61 1.2×	9	411
Yinci Zhang China	15	252 0.8×	98 1.2×	67 0.9×	84 1.2×	49 1.0×	23	458
Chang‐Chun Ling China	12	235 0.8×	96 1.1×	90 1.3×	66 0.9×	108 2.2×	24	530
Fang Sui China	14	394 1.3×	142 1.7×	63 0.9×	137 2.0×	85 1.7×	33	663
Amin Li China	15	233 0.8×	80 1.0×	84 1.2×	88 1.3×	57 1.2×	25	428
Pinjiang Cao Canada	11	327 1.1×	87 1.0×	60 0.8×	176 2.5×	74 1.5×	16	518

Countries citing papers authored by S. Neslihan Alpay

Since Specialization

Citations

This map shows the geographic impact of S. Neslihan Alpay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Neslihan Alpay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Neslihan Alpay more than expected).

Fields of papers citing papers by S. Neslihan Alpay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Neslihan Alpay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Neslihan Alpay. The network helps show where S. Neslihan Alpay may publish in the future.

Co-authorship network of co-authors of S. Neslihan Alpay

This figure shows the co-authorship network connecting the top 25 collaborators of S. Neslihan Alpay. A scholar is included among the top collaborators of S. Neslihan Alpay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Neslihan Alpay. S. Neslihan Alpay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Tekedereli, İbrahim, Uǧur Akar, S. Neslihan Alpay, Gabriel Lopez‐Berestein, & Bülent Özpolat. (2018). Autophagy is Required to Regulate Mitochondria Renewal, Cell Attachment, and All-trans–Retinoic Acid–Induced Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Journal of Environmental Pathology Toxicology and Oncology. 38(1). 13–20. 5 indexed citations

Ashour, Ahmed A., Nilgün Gürbüz, S. Neslihan Alpay, et al.. (2014). Elongation factor‐2 kinase regulates TG2/β1 integrin/Src/uPAR pathway and epithelial–mesenchymal transition mediating pancreatic cancer cells invasion. Journal of Cellular and Molecular Medicine. 18(11). 2235–2251. 67 indexed citations

Tekedereli, İbrahim, S. Neslihan Alpay, Uǧur Akar, et al.. (2013). Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (−) and ER (+) Breast Cancer. Molecular Therapy — Nucleic Acids. 2. e121–e121. 84 indexed citations

Ashour, Ahmed A., Abdel‐Aziz H. Abdel‐Aziz, Ahmed M. Mansour, et al.. (2013). Targeting elongation factor-2 kinase (eEF-2K) induces apoptosis in human pancreatic cancer cells. APOPTOSIS. 19(1). 241–258. 72 indexed citations

Özpolat, Bülent, Uǧur Akar, İbrahim Tekedereli, et al.. (2012). PKCδRegulates Translation Initiation through PKR and eIF2αin Response to Retinoic Acid in Acute Myeloid Leukemia Cells. PubMed. 2012. 1–17. 8 indexed citations

Tekedereli, İbrahim, S. Neslihan Alpay, Clint D.J. Tavares, et al.. (2012). Targeted Silencing of Elongation Factor 2 Kinase Suppresses Growth and Sensitizes Tumors to Doxorubicin in an Orthotopic Model of Breast Cancer. PLoS ONE. 7(7). e41171–e41171. 99 indexed citations

Ghosh, Sukhen C., S. Neslihan Alpay, & Jim Klostergaard. (2012). CD44: a validated target for improved delivery of cancer therapeutics. Expert Opinion on Therapeutic Targets. 16(7). 635–650. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact